A detailed history of Group One Trading, L.P. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 705 shares of PRPH stock, worth $549. This represents 0.0% of its overall portfolio holdings.

Number of Shares
705
Holding current value
$549
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.18 - $7.35 $2,946 - $5,181
705 New
705 $2,000
Q2 2022

Aug 11, 2022

SELL
$6.52 - $13.24 $31,745 - $64,465
-4,869 Reduced 96.05%
200 $3,000
Q1 2022

May 12, 2022

BUY
$6.2 - $7.87 $10,347 - $13,135
1,669 Added 49.09%
5,069 $35,000
Q4 2021

Feb 11, 2022

BUY
$5.13 - $7.89 $17,442 - $26,826
3,400 New
3,400 $24,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $12.5M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.